Analytical Data
-
基因名
TAFA4
- Application
-
别名
TAFA-4; Chemokine-like protein TAFA-4
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 95% as determined by SDS-PAGE.
-
蛋白编号
Q96LR4
-
表达区间
His46~Thr139
-
分子量
15kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TAFA4 is a member of the TAFA family of proteins, which are characterized by their unique structural motifs and are known to play roles in various biological processes. Recent studies have highlighted the potential functions of TAFA4 in modulating immune response, neuronal differentiation, and tissue repair. Its expression pattern is particularly interesting as it is prominently found in the central nervous system and immune cells, suggesting a crucial role in neuroinflammatory conditions and neurodegenerative diseases. The re-engineering of TAFA4 into recombinant proteins has drawn attention for its potential therapeutic applications, especially in the context of neurological disorders. Scholars have focused on understanding the mechanisms by which TAFA4 influences cellular pathways to promote neuroprotection and regenerative processes. Furthermore, characterizing its interactions with other biomolecules aims to elucidate the signaling networks involved, paving the way for novel treatments targeting TAFA4-related pathways. Data pertaining to the structural composition, biological activity, and receptor binding of TAFA4 is essential to fully grasp its function and therapeutic potential. Overall, the research on TAFA4 recombinant proteins represents a promising frontier in biomedical science, with implications for treating diverse conditions linked to immune and neural dysfunctions.












